ADVANZ PHARMA has collaborated with Veeva Systems to set up a unified digital-first commercial foundation in Europe.

ADVANZ intends to drive a unified field strategy across all markets and strengthen field engagement with healthcare professionals (HCPs) using Veeva Commercial Cloud, a family of data, software and services for advancing commercial excellence in life sciences.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

ADVANZ is also using Veeva OpenData and Veeva CRM Suite to consolidate its operations and to gain a clear understanding of customers throughout the healthcare ecosystem, with a focus on products within oncology, anti-infectives, critical care, endocrinology and rare diseases.

This allows the company’s newly merged field teams to coordinate more effectively with HCP touchpoints across channels and regions.

Veeva Europe commercial strategy vice-president Philipp Luik stated: “With Veeva Commercial Cloud, ADVANZ now has a digital foundation to sustain growth as it expands operations in Europe.

“By reaching the right people sooner and leading more impactful conversations, ADVANZ can advance its mission to improve patient outcomes.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

ADVANZ will also benefit from a deep understanding of important experts and from scientific awareness. It will gain support for therapies and medicines across its portfolio, enabled by the Veeva Link Key People and Veeva Link Scientific Awareness data applications.

Veeva Systems stated that Link is integrated with its Veeva CRM and Veeva OpenData, providing a connected data ecosystem for ADVANZ to lead precision engagement.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact